Want to stay ahead of who & what is next? Sent twice-a-week, the Beat is your definitive look at Richmond’s innovation ...
ICU Medical (ICUI) and Otsuka Pharmaceutical Factory, global IV solutions manufacturing subsidiary of Otsuka Holdings Co., Ltd., together announce the creation of a joint venture to provide additional ...
Multinational pharmaceutical companies will showcase their latest innovations at the upcoming China International Import Expo, which they see as an ideal chance for China to share opportunities with ...
The growth in the historic period can be attributed to early drug delivery innovations, pharmaceutical industry adoption, clinical studies and efficacy, market penetration strategies, disease ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
The pharmaceutical solvents industry size is securing a valuation ... Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise. Associate Vice President at ...
It all comes down to cost benefit, and having a set of priorities. In conducting hundreds of innovation workshops around the world for the public and private sectors, many of which have been ...
This page features the latest news about the Innovation Pharma stock. Innovation Pharmaceuticals Provides Update on U.S. Patent Applications Covering Use of Brilacidin in Inflammatory Bowel ...
Multinational pharmaceutical companies will showcase their latest innovations at the upcoming China International Import Expo, which they see as an ideal chance for China to share opportunities ...
The Minister of Innovation, Science, and Technology, Chief Uche Nnaji, has established a strategic partnership with Switzerland’s École Polytechnique Fédérale de Lausanne Innovation Park.
It is a fictional representation created for illustrative purposes only. In a recent update, pharmaceutical giant Roche has opposed Novo Nordisk's attempt to acquire drug manufacturer Catalent, citing ...